Rivaroxaban Export Market Intelligence: India's 221 Suppliers Shipping to 115 Countries — TransData Nexus 2026

Q: Who are the top rivaroxaban exporters from India?

The top rivaroxaban exporters from India are: 1. MYLAN LABORATORIES LIMITED — $17.0M (32.3% market share); 2. DR.REDDY'S LABORATORIES LTD — $5.2M (9.9% market share); 3. ZENTIVA PRIVATE LIMITED — $3.2M (6.1% market share); 4. CARITAS HEALTHCARE PRIVATE LIMITED — $3.2M (6.0% market share); 5. MICRO LABS LIMITED — $2.4M (4.5% market share). Together they account for 58.8% of India's total rivaroxaban export value.

Q: What is the total export value of rivaroxaban from India?

The total export value of rivaroxaban from India is $52.6M USD, recorded across 5,361 shipment transactions from 221 active exporters to 115 destination countries. The average shipment value is $9.8K.

Q: Which countries import rivaroxaban from India?

India exports rivaroxaban to 115 countries worldwide. The top importing countries are: NETHERLANDS (29.9% share, $15.7M), MALTA (9.6% share, $5.0M), ECUADOR (6.2% share, $3.2M), CANADA (6.0% share, $3.2M), BRAZIL (5.0% share, $2.6M). These five markets account for 56.7% of total export value.

Q: What is the HS code for rivaroxaban exports from India?

The primary HS code for rivaroxaban exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of rivaroxaban exports from India?

The average unit price for rivaroxaban exports from India is $7.08 USD per unit, with prices ranging from $0.00 to $1672.11 depending on formulation, packaging, and order volume. The total market is valued at $52.6M across 5,361 shipments.

Q: Which ports handle rivaroxaban exports from India?

The primary ports for rivaroxaban exports from India are SAHAR AIR (21.3% of shipments), DELHI AIR CARGO ACC (INDEL4) (18.4% of shipments), DELHI AIR (12.3% of shipments), SAHAR AIR CARGO ACC (INBOM4) (11.8% of shipments), Bombay Air (3.7% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of rivaroxaban?

India is one of the world's leading exporters of rivaroxaban due to its large base of 221 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports rivaroxaban to 115 countries, demonstrating 59% global market coverage.

Q: What certifications do Indian rivaroxaban exporters need?

Indian rivaroxaban exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import rivaroxaban from India?

There are 497 registered buyers importing rivaroxaban from India, spread across 115 countries. The repeat buyer rate is 75.3%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top rivaroxaban supplier from India?

MYLAN LABORATORIES LIMITED is the leading rivaroxaban exporter from India with a market share of 32.3% and total export value of $17.0M across 257 shipments. The top 5 suppliers together control 58.8% of total export value.

Suresh Sormare

Rivaroxaban

India Pharmaceutical Trade Intelligence

$52.6M221 Suppliers115 CountriesHS 30049099

ExportsIndia → NETHERLANDS29.9%India → MALTA9.6%

ImportsGERMANY → India$34.1B CANADA → India$46.0K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN IRELAND

Rivaroxaban Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Rivaroxaban to the World

Between 2022 and 2026, India exported $52.6M worth of rivaroxaban across 5,361 verified shipments to 115 countries — covering 59% of world markets in the Cardiovascular segment. The largest destination is NETHERLANDS (29.9%). MYLAN LABORATORIES LIMITED leads with a 32.3% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Rivaroxaban export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Rivaroxaban export data snapshot — $52.6M · 221 exporters · 115 countriesTransData Nexus · Indian Customs Data

Top Rivaroxaban Exporters from India

221 active exporters · Ranked by export value

View all 221 →

Top Rivaroxaban Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MYLAN LABORATORIES LIMITED	$17.0M	257	11	32.3%
2	DR.REDDY'S LABORATORIES LTD

Top Countries Importing Rivaroxaban from India

115 destination markets · Ranked by import value

All 115 countries →

Top Countries Importing Rivaroxaban from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	NETHERLANDS	$15.7M	29.9%
2	MALTA	$5.0M	9.6%
3	ECUADOR	$3.2M	6.2%
4	CANADA	$3.2M	6.0%
5	BRAZIL	$2.6M	5.0%
6	AUSTRALIA	$2.4M	4.6%
7	UNITED KINGDOM	$2.3M	4.4%
8	SOUTH AFRICA	$1.4M	2.7%
9	FRANCE	$1.3M	2.4%
10	CHILE	$1.2M	2.4%

NETHERLANDS is India's largest rivaroxaban export destination, absorbing 29.9% of total exports worth $15.7M. The top 5 importing countries — NETHERLANDS, MALTA, ECUADOR, CANADA, BRAZIL — together account for 56.7% of India's total rivaroxaban export value. The remaining 110 destination countries collectively receive the other 43.3%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Rivaroxaban to India?

30 origin countries · Total import value: $34.1B

India imports rivaroxaban from 30 countries with a combined import value of $34.1B. The largest supplier is GERMANY ($34.1B, 129 shipments), followed by UNITED STATES and UNITED KINGDOM. All values are from Indian Customs (DGFT) import records.

Countries Supplying Rivaroxaban to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	GERMANY	$34.1B	129	100.0%
2	UNITED STATES	$2.3M	82	0.0%
3	UNITED KINGDOM	$91.8K	36	0.0%
4	CANADA	$46.0K	43	0.0%
5	CHINA	$34.4K	14	0.0%
6	AUSTRALIA	$28.2K	20	0.0%
7	DENMARK	$21.6K	4	0.0%
8	IRELAND	$8.4K	5	0.0%
9	JAPAN	$7.7K	2	0.0%
10	THAILAND	$6.9K	3	0.0%

Showing top 10 of 30 origin countries

GERMANY is the largest supplier of rivaroxaban to India, accounting for 100.0% of total import value. The top 5 origin countries — GERMANY, UNITED STATES, UNITED KINGDOM, CANADA, CHINA — together supply 100.0% of India's rivaroxaban imports. Click any country to see detailed supplier and buyer data for that import corridor.

Rivaroxaban — Export Intelligence Video

Visual overview of India's rivaroxaban import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's rivaroxaban pharmaceutical import and export market — $52.6M in total trade, 221 verified manufacturers, and 115 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Rivaroxaban

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, rivaroxaban is marketed under the brand name Xarelto. The FDA has approved multiple Abbreviated New Drug Applications (ANDAs) for generic versions of rivaroxaban. For instance, on November 12, 2021, the FDA approved an ANDA for Rivaroxaban Tablets, 2.5 mg, submitted by Viatris Limited. Additionally, on June 10, 2024, the FDA approved a group of variations for Rivaroxaban Viatris, including changes in pack sizes. These approvals indicate a growing acceptance of generic rivaroxaban in the U.S. market. Notably, MYLAN LABORATORIES LIMITED, a leading exporter from India, has a significant presence in the U.S. market, reflecting the global reach of Indian pharmaceutical companies.

2EU & UK Regulatory Framework

In the European Union, the European Medicines Agency (EMA) granted marketing authorization for Xarelto (rivaroxaban) on September 30, 2008. Subsequently, generic versions have been approved, such as Rivaroxaban Accord on November 16, 2020, and Rivaroxaban Viatris on November 12, 2021. The EMA has also provided product-specific bioequivalence guidance for rivaroxaban, effective January 1, 2026, to ensure consistent quality and efficacy among generics. In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) aligns with EMA standards, requiring compliance with Good Manufacturing Practice (GMP) for marketing authorization. The significant export volumes to the Netherlands and Malta underscore the importance of the EU market for Indian exporters.

3WHO Essential Medicines & Global Standards

Rivaroxaban is included in the 21st edition of the WHO Model List of Essential Medicines, highlighting its critical role in global health. While specific WHO Prequalification for rivaroxaban is not detailed, adherence to international pharmacopoeia standards such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP) is essential for market acceptance. Compliance with these standards ensures the quality and safety of rivaroxaban products in international markets.

4India Regulatory Classification

In India, rivaroxaban is classified under Schedule H, indicating it is a prescription-only medication. The Drug Price Control Order (DPCO) and the National Pharmaceutical Pricing Authority (NPPA) regulate its pricing; however, specific ceiling prices are subject to periodic revisions. Export of rivaroxaban requires a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national regulations.

5Patent & Exclusivity Status

The primary patents for rivaroxaban have expired, allowing for the introduction of generic versions. This has led to increased competition among manufacturers, including Indian exporters, contributing to the substantial export figures and the presence of multiple active exporters in the market.

6Recent Industry Developments

In July 2025, the EMA adopted revised bioequivalence guidance for rivaroxaban, effective January 1, 2026, to ensure uniform standards for generic formulations. In September 2025, the EMA approved Rivaroxaban Koanaa, a generic version, expanding the availability of rivaroxaban in the EU market. In November 2025, the EMA updated the product information for Rivaroxaban Viatris, reflecting ongoing regulatory oversight. In June 2024, the FDA approved a group of variations for Rivaroxaban Viatris, including changes in pack sizes, indicating continuous regulatory engagement. In November 2023, the EMA adopted a positive opinion recommending changes to the marketing authorization for Pradaxa, another anticoagulant, reflecting the dynamic nature of the anticoagulant market.

These developments underscore the evolving regulatory landscape for rivaroxaban, with Indian exporters playing a pivotal role in supplying global markets.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Rivaroxaban

Retail & reference prices across 9 markets vs. India FOB export price of $7.08/unit

Global Price Benchmark for Rivaroxaban across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$12.00	USD	According to the FDA's Orange Book, Rivaroxaban is approved for various indications, and pricing is subject to market dynamics and insurance coverage.
United Kingdom	$3.25	GBP	As per the NHS Drug Tariff, Rivaroxaban is listed for reimbursement, with prices negotiated under the Voluntary Scheme for Branded Medicines Pricing and Access.
Germany	$3.30	EUR	The Federal Joint Committee (G-BA) includes Rivaroxaban in its reimbursement list, with prices determined through negotiations with statutory health insurance funds.

Supply Chain Risk Assessment — Rivaroxaban

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry heavily relies on China for Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs), with approximately 70% of KSMs imported from China as of 2023. This dependency exposes the supply chain to risks associated with geopolitical tensions and regulatory changes in China. For instance, in 2018, environmental regulations in China led to the shutdown of numerous chemical plants, causing significant disruptions in the supply of KSMs and subsequent price increases for APIs.

The COVID-19 pandemic further highlighted these vulnerabilities, as lockdowns and export restrictions in China during early 2020 disrupted the supply of essential raw materials, leading to production delays and increased costs for Indian pharmaceutical manufacturers. Such events underscore the critical need for India to develop domestic capabilities in KSM and API production to mitigate future supply chain risks.

2Supplier Concentration & Single-Source Risk

The export market for Rivaroxaban is notably concentrated, with the top five exporters accounting for 58.8% of total exports. MYLAN LABORATORIES LIMITED alone holds a 32.3% share, indicating a significant reliance on a limited number of suppliers. This concentration poses a risk of supply disruptions if any of these key exporters face operational challenges.

Access Complete Rivaroxaban Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 5,361 transactions across 115 markets.

Request Demo View Pricing

Frequently Asked Questions — Rivaroxaban Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top rivaroxaban exporters from India?

The leading rivaroxaban exporters from India are MYLAN LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD, ZENTIVA PRIVATE LIMITED, and 12 others. MYLAN LABORATORIES LIMITED leads with 32.3% market share ($17.0M). The top 5 suppliers together control 58.8% of total export value.

What is the total export value of rivaroxaban from India?

The total export value of rivaroxaban from India is $52.6M, recorded across 5,361 shipments from 221 active exporters to 115 countries. The average shipment value is $9.8K.

Which countries import rivaroxaban from India?

India exports rivaroxaban to 115 countries. The top importing countries are NETHERLANDS (29.9%), MALTA (9.6%), ECUADOR (6.2%), CANADA (6.0%), BRAZIL (5.0%), which together account for 56.7% of total export value.

What is the HS code for rivaroxaban exports from India?

The primary HS code for rivaroxaban exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Rivaroxaban

Rivaroxaban

Top Rivaroxaban Exporters from India

Top Countries Importing Rivaroxaban from India

Who Supplies Rivaroxaban to India?

Quick Facts

Related Cardiovascular

Related Analysis

Need Details?

Rivaroxaban — Export Intelligence Video

Regulatory Landscape — Rivaroxaban

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Rivaroxaban

Supply Chain Risk Assessment — Rivaroxaban

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Rivaroxaban Trade Intelligence

Frequently Asked Questions — Rivaroxaban Exports from India

Who are the top rivaroxaban exporters from India?

What is the total export value of rivaroxaban from India?

Which countries import rivaroxaban from India?

What is the HS code for rivaroxaban exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of rivaroxaban exports from India?

Which ports handle rivaroxaban exports from India?

Why is India a leading exporter of rivaroxaban?

What certifications do Indian rivaroxaban exporters need?

How many buyers import rivaroxaban from India?

What is the market share of the top rivaroxaban exporter from India?

Analysis Methodology